Tolmar - About the company
Tolmar is an acquired company based in Fort Collins (United States), founded in 2007. It operates as a Pharmaceutical company delivering innovative, long-acting injectable treatments to improve patient lives.
Company Details
Pharmaceutical company delivering innovative, long-acting injectable treatments to improve patient lives. They are dedicated to improving experiences and outcomes for patients and healthcare providers. They specialize in long-acting injectables within urology, oncology, and endocrinology, focusing on areas like prostate cancer, central precocious puberty, and testosterone replacement therapy. The company is committed to research and development, commercialization, and manufacturing to meet unmet medical needs. They prioritize patient support, education, and access to treatments. Their approach involves continuous improvement, sustainability, and partnerships to deliver meaningful solutions and advance patient care. They embody values like proactive action, ethical conduct, constant improvement, accountability, and centering on people to drive innovation and make a difference in the pharmaceutical landscape.
- Website
- tolmar.com
- Registered Address
- Fort Collins, Colorado
Key Metrics
Founded Year
2007
Location
Fort Collins, United States
Stage
Acquired
Employee Count
893 as on Dec 31, 2021
Exit Details
Acquired by Mundipharma (Feb 19, 2018)
Legal entities associated with Tolmar
Tolmar is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
TOLMAR, INC. CIN: 205990340 , United States, Active | Dec 26, 999 | - | 893 (As on Dec 31, 2021) | - |
TOLMAR Pharmaceuticals Inc. CIN: 20141087297 , United States, Deadpooled | Feb 06, 2014 | - | - | - |
Tolmar, Inc. CIN: 10231874 , United States, Active | Mar 29, 2023 | - | - | - |
Tolmar's acquisition details
Tolmar got acquired by Mundipharma on Feb 19, 2018. It was facilitated by Henslow, Oaklins and Saltire Capital Partners.
Click here to take a look at Tolmar's acquisition in detail
Sign up to download Tolmar's company profile
Tolmar's funding and investors
Tolmar has not raised any funding rounds yet.
Tolmar's founders and board of directors
Founder? Claim ProfileTolmar's employee count trend
Tolmar has 893 employees as of Dec 21. The total employee count is 5.0% more than what it was in Dec 20. Here is Tolmar's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Tolmar's Investments and acquisitions
Tolmar has made 1 investment in DelSiTech and acquired JATENZO.Reports related to Tolmar
Here is the latest report on Tolmar's sector:
News related to Tolmar
Media has covered Tolmar for a total of 2 events in the last 1 year, 2 of them have been about company updates.
•
•
Tolmar Expands with New Lab at Rosalind Franklin University's Innovation ParkPR Newswire•Dec 17, 2025•Tolmar
•
•
DelSiTech and Tolmar International Sign Global License & Development AgreementContract Pharma•Feb 13, 2024•DelSiTech, Tolmar
•
•
•
Tolmar wins auction for testosterone therapy Jatenzo under Clarus' bankruptcy proceedingsSeeking Alpha•Oct 28, 2022•Tolmar, JATENZO, Clarus Therapeutics
•
•
•
Are you a Founder ?
FAQs about Tolmar
Explore our recently published companies
- Lint - Kyoto based, 2017 founded, Unfunded company
- Stertekautoclave - Unfunded company
- Ail-Tech - Germany based, Unfunded company
- Frescolabs - United Kingdom based, Unfunded company
- Genewelltech - 2021 founded, Unfunded company
- Techbeyond - Unfunded company